Pfizer, Sumitomo, Takeda oppose MSN generic application for Orgovyx in US
MLex Summary: Pfizer, Sumitomo Pharma and Takeda Pharmaceuticals filed a patent infringement suit in the US District of Delaware against MSN Pharmaceuticals in opposition to MSN’s Abbreviated New Drug Application to...To view the full article, register now.
Already a subscriber? Click here to view full article